Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections
|
摘要
The yeast Saccharomyces boulardii CNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-associated diarrhea. Studies conducted in vivo and in vitro demonstrated that in the case of infectious diseases there are two potential sites of action of Saccharomyces boulardii CNCM I-745:(1)An action on enteropathogenic microorganisms(adhesion of bacteria and their elimination or an effect on their virulence factors: Toxins, lipopolysaccharide,etc.); and(2) a direct action on the intestinal mucosa(trophic effects, effects on epithelial reconstitution, anti-secretory effects, anti-inflammatory,immunomodulators). Oral administration of Saccharomyces boulardii CNCM I-745 to healthy subjects does not alter their microbiota. However, in the case of diseases associated with the use of antibiotics or chronic diarrhea, Saccharomyces boulardii CNCM I-745 can restore the intestinal microbiota faster. The interaction of Saccharomyces boulardii CNCM I-745 with the innate immune system have been recently demonstrated thus opening up a new therapeutic potential of this yeast in the case of diseases associated with intestinal infections but also other pathologies associated with dysbiosis such as inflammatory diseases.
The yeast Saccharomyces boulardii CNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-associated diarrhea. Studies conducted in vivo and in vitro demonstrated that in the case of infectious diseases there are two potential sites of action of Saccharomyces boulardii CNCM I-745:(1)An action on enteropathogenic microorganisms(adhesion of bacteria and their elimination or an effect on their virulence factors: Toxins, lipopolysaccharide,etc.); and(2) a direct action on the intestinal mucosa(trophic effects, effects on epithelial reconstitution, anti-secretory effects, anti-inflammatory,immunomodulators). Oral administration of Saccharomyces boulardii CNCM I-745 to healthy subjects does not alter their microbiota. However, in the case of diseases associated with the use of antibiotics or chronic diarrhea, Saccharomyces boulardii CNCM I-745 can restore the intestinal microbiota faster. The interaction of Saccharomyces boulardii CNCM I-745 with the innate immune system have been recently demonstrated thus opening up a new therapeutic potential of this yeast in the case of diseases associated with intestinal infections but also other pathologies associated with dysbiosis such as inflammatory diseases.
The yeast Saccharomyces boulardii CNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-associated diarrhea. Studies conducted in vivo and in vitro demonstrated that in the case of infectious diseases there are two potential sites of action of Saccharomyces boulardii CNCM I-745:(1)An action on enteropathogenic microorganisms(adhesion of bacteria and their elimination or an effect on their virulence factors: Toxins, lipopolysaccharide,etc.); and(2) a direct action on the intestinal mucosa(trophic effects, effects on epithelial reconstitution, anti-secretory effects, anti-inflammatory,immunomodulators). Oral administration of Saccharomyces boulardii CNCM I-745 to healthy subjects does not alter their microbiota. However, in the case of diseases associated with the use of antibiotics or chronic diarrhea, Saccharomyces boulardii CNCM I-745 can restore the intestinal microbiota faster. The interaction of Saccharomyces boulardii CNCM I-745 with the innate immune system have been recently demonstrated thus opening up a new therapeutic potential of this yeast in the case of diseases associated with intestinal infections but also other pathologies associated with dysbiosis such as inflammatory diseases.
引文
1 Czerucka D,Piche T,Rampal P.Review article:Yeast as probiotics--Saccharomyces boulardii.Aliment Pharmacol Ther 2007;26:767-778[PMID:17767461 DOI:10.1111/j.1365-2036.2007.03442.x]
2 Neut C,Mathieux S,Dubreuil LJ.Antibiotic susceptibility of probiotics strains:Is it reasonable to combine probiotics with antibiotics?Méd Malad infect 2017;47:477-483[DOI:10.1016/j.medmal.2017.07.001]
3 Surawicz CM,Elmer GW,Speelman P,McFarland LV,Chinn J,van Belle G.Prevention of antibioticassociated diarrhea by Saccharomyces boulardii:A prospective study.Gastroenterology 1989;96:981-988[PMID:2494098 DOI:10.1016/0016-5085(89)91613-2]
4 McFarland LV,Surawicz CM,Greenberg RN,Elmer GW,Moyer KA,Melcher SA,Bowen KE,Cox JL.Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.Am JGastroenterol 1995;90:439-448[PMID:7872284]
5 Adam J,Barret A,Barret-Bellet C.Essais cliniques contr?lés en double insu de l'Ultra-Levure lyophilisée.Etude multicentrique par 25 médecins de 388 cas.Méd Chirurg Dig 1976;5:401-405
6 Kotowska M,Albrecht P,Szajewska H.Saccharomyces boulardii in the prevention of antibioticassociated diarrhoea in children:A randomized double-blind placebo-controlled trial.Aliment Pharmacol Ther 2005;21:583-590[PMID:15740542 DOI:10.1111/j.1365-2036.2005.02356.x]
7 Shan LS,Hou P,Wang ZJ,Liu FR,Chen N,Shu LH,Zhang H,Han XH,Han XX,Cai XX,Shang YX,Vandenplas Y.Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections.Benef Microbes 2013;4:329-334[PMID:24311316 DOI:10.3920/BM2013.0008]
8 Szajewska H,Ko?odziej M.Systematic review with meta-analysis:Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Aliment Pharmacol Ther 2015;42:793-801[PMID:26216624 DOI:10.1111/apt.13344]
9 Szajewska H,Mrukowicz J.Meta-analysis:Non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Aliment Pharmacol Ther 2005;22:365-372[PMID:16128673 DOI:10.1111/j.1365-2036.2005.02624.x]
10 Surawicz CM,McFarland LV,Elmer G,Chinn J.Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.Am J Gastroenterol 1989;84:1285-1287[PMID:2679049]
11 McFarland LV,Surawicz CM,Greenberg RN,Fekety R,Elmer GW,Moyer KA,Melcher SA,Bowen KE,Cox JL,Noorani Z.A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.JAMA 1994;271:1913-1918[PMID:8201735 DOI:10.1001/jama.1994.03510480037031]
12 Surawicz CM,McFarland LV,Greenberg RN,Rubin M,Fekety R,Mulligan ME,Garcia RJ,Brandmarker S,Bowen K,Borjal D,Elmer GW.The search for a better treatment for recurrent Clostridium difficile disease:Use of high-dose vancomycin combined with Saccharomyces boulardii.Clin Infect Dis 2000;31:1012-1017[PMID:11049785 DOI:10.1086/318130]
13 Dinleyici EC,Kara A,Ozen M,Vandenplas Y.Saccharomyces boulardii CNCM I-745 in different clinical conditions.Expert Opin Biol Ther 2014;14:1593-1609[PMID:24995675 DOI:10.1517/14712598.2014.937419]
14 Villarruel G,Rubio DM,Lopez F,Cintioni J,Gurevech R,Romero G,Vandenplas Y.Saccharomyces boulardii in acute childhood diarrhoea:A randomized,placebo-controlled study.Acta Paediatr 2007;96:538-541[PMID:17306006 DOI:10.1111/j.1651-2227.2007.00191.x]
15 Dinleyici EC,Eren M,Ozen M,Yargic ZA,Vandenplas Y.Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea.Expert Opin Biol Ther 2012;12:395-410[PMID:22335323 DOI:10.1517/14712598.2012.664129]
16 Kurug?l Z,Koturo?lu G.Effects of Saccharomyces boulardii in children with acute diarrhoea.Acta Paediatr 2005;94:44-47[PMID:15858959 DOI:10.1111/j.1651-2227.2005.tb01786.x]
17 Billoo AG,Memon MA,Khaskheli SA,Murtaza G,Iqbal K,Saeed Shekhani M,Siddiqi AQ.Role of a probiotic(Saccharomyces boulardii)in management and prevention of diarrhoea.World J Gastroenterol2006;12:4557-4560[PMID:16874872 DOI:10.3748/wjg.v12.i28.4557]
18 Htwe K,Yee KS,Tin M,Vandenplas Y.Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children:A randomized controlled study.Am J Trop Med Hyg 2008;78:214-216[PMID:18256417 DOI:10.4269/ajtmh.2008.78.214]
19 Kollaritsch H,Kremser P,Wiedermann G,Schneider O.Prevention of traveler's diarrhea:Comparison of different non antibiotic preparation.Travel Med Int 1989;9-17
20 Kollaritsch H,Holst H,Grobara P,Wiedermann G.[Prevention of traveler's diarrhea with Saccharomyces boulardii.Results of a placebo controlled double-blind study].Fortschr Med 1993;111:152-156[PMID:8486328]
21 Vidon N,Huchet B,Rambaud JC.[Influence of Saccharomyces boulardii on jejunal secretion in rats induced by cholera toxin].Gastroenterol Clin Biol 1986;10:13-16[PMID:3956910]
22 Czerucka D,Rampal P.Effect of Saccharomyces boulardii on cAMP-and Ca2+-dependent Cl-secretion in T84 cells.Dig Dis Sci 1999;44:2359-2368[PMID:10573387 DOI:10.1023/A:1026689628136]
23 Czerucka D,Roux I,Rampal P.Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells.Gastroenterology 1994;106:65-72[PMID:8276210DOI:10.1016/S0016-5085(94)94403-2]
24 Brand?o RL,Castro IM,Bambirra EA,Amaral SC,Fietto LG,Tropia MJ,Neves MJ,Dos Santos RG,Gomes NC,Nicoli JR.Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae.Appl Environ Microbiol 1998;64:564-568[PMID:9464394 DOI:10.1016/j.cattod.2009.07.111]
25 Toothaker RD,Elmer GW.Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.Antimicrob Agents Chemother 1984;26:552-556[PMID:6517545 DOI:10.1128/AAC.26.4.552]
26 Corthier G,Dubos F,Ducluzeau R.Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.Can J Microbiol 1986;32:894-896[PMID:3815159 DOI:10.1139/m86-164]
27 Corthier G,Lucas F,Jouvert S,Castex F.Effect of oral Saccharomyces boulardii treatment on the activity of Clostridium difficile toxins in mouse digestive tract.Toxicon 1992;30:1583-1589[PMID:1488767 DOI:10.1016/0041-0101(92)90030-9]
28 Koon HW,Su B,Xu C,Mussatto CC,Tran DH,Lee EC,Ortiz C,Wang J,Lee JE,Ho S,Chen X,Kelly CP,Pothoulakis C.Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.Am J Physiol Gastrointest Liver Physiol2016;311:G610-G623[PMID:27514478 DOI:10.1152/ajpgi.00150.2016]
29 Pothoulakis C,Kelly CP,Joshi MA,Gao N,O'Keane CJ,Castagliuolo I,Lamont JT.Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.Gastroenterology1993;104:1108-1115[PMID:8462799 DOI:10.1016/0016-5085(93)90280-P]
30 Castagliuolo I,LaMont JT,Nikulasson ST,Pothoulakis C.Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.Infect Immun 1996;64:5225-5232[PMID:8945570DOI:10.1016/S0928-8244(96)00073-9]
31 Chen X,Kokkotou EG,Mustafa N,Bhaskar KR,Sougioultzis S,O'Brien M,Pothoulakis C,Kelly CP.Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis.J Biol Chem 2006;281:24449-24454[PMID:16816386 DOI:10.1074/jbc.M605200200]
32 Qamar A,Aboudola S,Warny M,Michetti P,Pothoulakis C,LaMont JT,Kelly CP.Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.Infect Immun 2001;69:2762-2765[PMID:11254650 DOI:10.1128/IAI.69.4.2762-2765.2001]
33 Pontier-Bres R,Rampal P,Peyron JF,Munro P,Lemichez E,Czerucka D.The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B.anthracis LT toxin.Toxins(Basel)2015;7:4455-4467[PMID:26529015 DOI:10.3390/toxins7114455]
34 Czerucka D,Dahan S,Mograbi B,Rossi B,Rampal P.Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coliinfected T84 cells.Infect Immun 2000;68:5998-6004[PMID:10992512 DOI:10.1128/IAI.68.10.5998-6004.2000]
35 Dahan S,Dalmasso G,Imbert V,Peyron JF,Rampal P,Czerucka D.Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.Infect Immun 2003;71:766-773[PMID:12540556 DOI:10.1128/IAI.71.2.766-773.2003]
36 Wu X,Vallance BA,Boyer L,Bergstrom KS,Walker J,Madsen K,O'Kusky JR,Buchan AM,Jacobson K.Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.Am J Physiol Gastrointest Liver Physiol 2008;294:G295-G306[PMID:18032474 DOI:10.1152/ajpgi.00173.2007]
37 Buts JP,Dekeyser N,Stilmant C,Delem E,Smets F,Sokal E.Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation.Pediatr Res 2006;60:24-29[PMID:16690953 DOI:10.1203/01.pdr.0000220322.31940.29]
38 Rodrigues AC,Nardi RM,Bambirra EA,Vieira EC,Nicoli JR.Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.J Appl Bacteriol 1996;81:251-256[PMID:8810053 DOI:10.1111/j.1365-2672.1996.tb04325.x]
39 Martins FS,Dalmasso G,Arantes RM,Doye A,Lemichez E,Lagadec P,Imbert V,Peyron JF,Rampal P,Nicoli JR,Czerucka D.Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection.PLoS One 2010;5:e8925[PMID:20111723 DOI:10.1371/journal.pone.0008925]
40 Pontier-Bres R,Munro P,Boyer L,Anty R,Imbert V,Terciolo C,AndréF,Rampal P,Lemichez E,Peyron JF,Czerucka D.Saccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tract.PLoS One 2014;9:e103069[PMID:25118595 DOI:10.1371/journal.pone.0103069]
41 Pontier-Bres R,Prodon F,Munro P,Rampal P,Lemichez E,Peyron JF,Czerucka D.Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardii.PLoS One 2012;7:e33796[PMID:22442723 DOI:10.1371/journal.pone.0033796]
42 Mumy KL,Chen X,Kelly CP,McCormick BA.Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.Am J Physiol Gastrointest Liver Physiol 2008;294:G599-G609[PMID:18032477 DOI:10.1152/ajpgi.00391.2007]
43 Gedek BR.Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT104 to the surface of Saccharomyces boulardii.Mycoses 1999;42:261-264[PMID:10424093 DOI:10.1046/j.1439-0507.1999.00449.x]
44 Duman DG,Bor S,Ozütemiz O,Sahin T,O?uz D,I?tan F,Vural T,Sandkci M,I?ksal F,Sim?ek I,Soytürk M,Arslan S,Sivri B,Soykan I,Temizkan A,Be??k F,Kaymako?lu S,Kalayc C.Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication.Eur J Gastroenterol Hepatol 2005;17:1357-1361[PMID:16292090 DOI:10.1097/00042737-200512000-00015]
45 Cindoruk M,Erkan G,Karakan T,Dursun A,Unal S.Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy:A prospective randomized placebo-controlled doubleblind study.Helicobacter 2007;12:309-316[PMID:17669103 DOI:10.1111/j.1523-5378.2007.00516.x]
46 Sakarya S,Gunay N.Saccharomyces boulardii expresses neuraminidase activity selective forα2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells.APMIS 2014;122:941-950[PMID:24628732 DOI:10.1111/apm.12237]
47 Yang L,Tian ZB,Yu YN,Zhang CP,Li XY,Mao T,Jing X,Zhao WJ,Ding XL,Yang RM,Zhang SQ.Saccharomyces boulardii administration can inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection.Pathog Dis 2017;75[PMID:28115360 DOI:10.1093/femspd/ftx006]
48 Guilbaub JF.Traitement des candidoses digestives et cutanéo-muqueuses par l'Ultra-levureàhaute dose.Vie méd 1975;8:628-630
49 Ducluzeau R,Bensaada M.[Comparative effect of a single or continuous administration of"Saccharomyces boulardii"on the establishment of various strains of"candida"in the digestive tract of gnotobiotic mice].Ann Microbiol(Paris)1982;133:491-501[PMID:6762128 DOI:10.1016/0141-4607(82)90006-3]
50 Berg R,Bernasconi P,Fowler D,Gautreaux M.Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii.J Infect Dis 1993;168:1314-1318[PMID:8228371 DOI:10.1093/infdis/168.5.1314]
51 Algin C,Sahin A,Kiraz N,Sahintürk V,Ihtiyar E.Effectiveness of bombesin and Saccharomyces boulardii against the translocation of Candida albicans in the digestive tract in immunosuppressed rats.Surg Today 2005;35:869-873[PMID:16175469 DOI:10.1007/s00595-005-3049-9]
52 Jawhara S,Poulain D.Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis.Med Mycol 2007;45:691-700[PMID:17885943 DOI:10.1080/13693780701523013]
53 Krasowska A,Murzyn A,Dyjankiewicz A,?ukaszewicz M,Dziadkowiec D.The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation,adhesion and biofilm formation.FEMS Yeast Res 2009;9:1312-1321[PMID:19732158 DOI:10.1111/j.1567-1364.2009.00559.x]
54 Murzyn A,Krasowska A,Stefanowicz P,Dziadkowiec D,?ukaszewicz M.Capric acid secreted by S.boulardii inhibits C.albicans filamentous growth,adhesion and biofilm formation.PLoS One 2010;5:e12050[PMID:20706577 DOI:10.1371/journal.pone.0012050]
55 Murzyn A,Krasowska A,Augustyniak D,Majkowska-Skrobek G,?ukaszewicz M,Dziadkowiec D.The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407.FEMS Microbiol Lett 2010;310:17-23[PMID:20629753 DOI:10.1111/j.1574-6968.2010.02037.x]
56 Fidan I,Kalkanci A,Yesilyurt E,Yalcin B,Erdal B,Kustimur S,Imir T.Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans.Mycoses 2009;52:29-34[PMID:18627477 DOI:10.1111/j.1439-0507.2008.01545.x]
57 Buccigrossi V,Laudiero G,Russo C,Miele E,Sofia M,Monini M,Ruggeri FM,Guarino A.Chloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytes.PLoS One 2014;9:e99830[PMID:24918938 DOI:10.1371/journal.pone.0099830]
58 Rigothier MC,Maccario J,Vuong PN,Gayral P.[Effects of Saccharomyces boulardii yeast on trophozoites of Entamoeba histolytica in vitro and in cecal amebiasis in young rats].Ann Parasitol Hum Comp 1990;65:51-60[PMID:2221756 DOI:10.1051/parasite/1990652051]
59 Rigothier MC,Maccario J,Gayral P.Inhibitory activity of saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro.Parasitol Res 1994;80:10-15[PMID:8153119 DOI:10.1007/BF00932617]
60 Schroeder B,Winckler C,Failing K,Breves G.Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum.Dig Dis Sci 2004;49:1311-1317[PMID:15387362 DOI:10.1023/B:DDAS.0000037828.05100.52]
61 Krammer M,Karbach U.Antidiarrheal action of the yeast Saccharomyces boulardii in the rat small and large intestine by stimulating chloride secretion.Z Gastroenterol 1993;31:73-77
62 Girard P,Pansart Y,Lorette I,Gillardin JM.Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats.Dig Dis Sci 2003;48:770-774[PMID:12741470 DOI:10.1023/A:1022801228938]
63 Breves G,Faul K,Schr?der B,Holst H,Caspary WF,Stein J.Application of the colon-simulation technique for studying the effects of Saccharomyces boulardii on basic parameters of porcine cecal microbial metabolism disturbed by clindamycin.Digestion 2000;61:193-200[PMID:10773725 DOI:10.1159/000007757]
64 Schneider SM,Girard-Pipau F,Filippi J,Hebuterne X,Moyse D,Hinojosa GC,Pompei A,Rampal P.Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition.World J Gastroenterol 2005;11:6165-6169[PMID:16273644 DOI:10.3748/wjg.v11.i39.6165]
65 Buts JP,Bernasconi P,Vaerman JP,Dive C.Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii.Dig Dis Sci 1990;35:251-256[PMID:2302983 DOI:10.1007/bf01536771]
66 Jahn HU,Ullrich R,Schneider T,Liehr RM,Schieferdecker HL,Holst H,Zeitz M.Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers.Digestion1996;57:95-104[PMID:8786007 DOI:10.1159/000201320]
67 Collignon A,SandréC,Barc MC.[Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment].Gastroenterol Clin Biol 2010;34 Suppl 1:S71-S78[PMID:20889009 DOI:10.1016/S0399-8320(10)70024-5]
68 Thomas S,Przesdzing I,Metzke D,Schmitz J,Radbruch A,Baumgart DC.Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation.Clin Exp Immunol 2009;156:78-87[PMID:19161443 DOI:10.1111/j.1365-2249.2009.03878.x]
69 Thomas S,Metzke D,Schmitz J,D?rffel Y,Baumgart DC.Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis.Am J Physiol Gastrointest Liver Physiol 2011;301:G1083-G1092[PMID:21903765 DOI:10.1152/ajpgi.00217.2011]
70 Ibanez L,Pontier-Bres R,Larbret F,Rekima A,Verhasselt V,Blin-Wakkach C,Czerucka D.Saccharomyces boulardii strain CNCM I-745 modifies the mononuclear response in the small intetine of mice following Salmonella Typhimurium infection.Front Immunol 2019;10:643[DOI:10.3389/fimmu.2019.00643.eCollection2019]
71 Barc MC,Charrin-Sarnel C,Rochet V,Bourlioux F,SandréC,Boureau H,DoréJ,Collignon A.Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment:Influence of Saccharomyces boulardii.Anaerobe 2008;14:229-233[PMID:18511310 DOI:10.1016/j.anaerobe.2008.04.003]
72 Swidsinski A,Loening-Baucke V,Verstraelen H,Osowska S,Doerffel Y.Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea.Gastroenterology 2008;135:568-579[PMID:18570896 DOI:10.1053/j.gastro.2008.04.017]
73 Swidsinski A,Loening-Baucke V,Schulz S,Manowsky J,Verstraelen H,Swidsinski S.Functional anatomy of the colonic bioreactor:Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders.Syst Appl Microbiol 2016;39:67-75[PMID:26723852 DOI:10.1016/j.syapm.2015.11.002]
74 Kabbani TA,Pallav K,Dowd SE,Villafuerte-Galvez J,Vanga RR,Castillo NE,Hansen J,Dennis M,Leffler DA,Kelly CP.Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.Gut Microbes 2017;8:17-32[PMID:27973989 DOI:10.1080/19490976.2016.1267890]
75 MoréMI,Swidsinski A.Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis-a review.Clin Exp Gastroenterol 2015;8:237-255[PMID:26316791 DOI:10.2147/CEG.S85574]
2 Neut C,Mathieux S,Dubreuil LJ.Antibiotic susceptibility of probiotics strains:Is it reasonable to combine probiotics with antibiotics?Méd Malad infect 2017;47:477-483[DOI:10.1016/j.medmal.2017.07.001]
3 Surawicz CM,Elmer GW,Speelman P,McFarland LV,Chinn J,van Belle G.Prevention of antibioticassociated diarrhea by Saccharomyces boulardii:A prospective study.Gastroenterology 1989;96:981-988[PMID:2494098 DOI:10.1016/0016-5085(89)91613-2]
4 McFarland LV,Surawicz CM,Greenberg RN,Elmer GW,Moyer KA,Melcher SA,Bowen KE,Cox JL.Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.Am JGastroenterol 1995;90:439-448[PMID:7872284]
5 Adam J,Barret A,Barret-Bellet C.Essais cliniques contr?lés en double insu de l'Ultra-Levure lyophilisée.Etude multicentrique par 25 médecins de 388 cas.Méd Chirurg Dig 1976;5:401-405
6 Kotowska M,Albrecht P,Szajewska H.Saccharomyces boulardii in the prevention of antibioticassociated diarrhoea in children:A randomized double-blind placebo-controlled trial.Aliment Pharmacol Ther 2005;21:583-590[PMID:15740542 DOI:10.1111/j.1365-2036.2005.02356.x]
7 Shan LS,Hou P,Wang ZJ,Liu FR,Chen N,Shu LH,Zhang H,Han XH,Han XX,Cai XX,Shang YX,Vandenplas Y.Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections.Benef Microbes 2013;4:329-334[PMID:24311316 DOI:10.3920/BM2013.0008]
8 Szajewska H,Ko?odziej M.Systematic review with meta-analysis:Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Aliment Pharmacol Ther 2015;42:793-801[PMID:26216624 DOI:10.1111/apt.13344]
9 Szajewska H,Mrukowicz J.Meta-analysis:Non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Aliment Pharmacol Ther 2005;22:365-372[PMID:16128673 DOI:10.1111/j.1365-2036.2005.02624.x]
10 Surawicz CM,McFarland LV,Elmer G,Chinn J.Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.Am J Gastroenterol 1989;84:1285-1287[PMID:2679049]
11 McFarland LV,Surawicz CM,Greenberg RN,Fekety R,Elmer GW,Moyer KA,Melcher SA,Bowen KE,Cox JL,Noorani Z.A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.JAMA 1994;271:1913-1918[PMID:8201735 DOI:10.1001/jama.1994.03510480037031]
12 Surawicz CM,McFarland LV,Greenberg RN,Rubin M,Fekety R,Mulligan ME,Garcia RJ,Brandmarker S,Bowen K,Borjal D,Elmer GW.The search for a better treatment for recurrent Clostridium difficile disease:Use of high-dose vancomycin combined with Saccharomyces boulardii.Clin Infect Dis 2000;31:1012-1017[PMID:11049785 DOI:10.1086/318130]
13 Dinleyici EC,Kara A,Ozen M,Vandenplas Y.Saccharomyces boulardii CNCM I-745 in different clinical conditions.Expert Opin Biol Ther 2014;14:1593-1609[PMID:24995675 DOI:10.1517/14712598.2014.937419]
14 Villarruel G,Rubio DM,Lopez F,Cintioni J,Gurevech R,Romero G,Vandenplas Y.Saccharomyces boulardii in acute childhood diarrhoea:A randomized,placebo-controlled study.Acta Paediatr 2007;96:538-541[PMID:17306006 DOI:10.1111/j.1651-2227.2007.00191.x]
15 Dinleyici EC,Eren M,Ozen M,Yargic ZA,Vandenplas Y.Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea.Expert Opin Biol Ther 2012;12:395-410[PMID:22335323 DOI:10.1517/14712598.2012.664129]
16 Kurug?l Z,Koturo?lu G.Effects of Saccharomyces boulardii in children with acute diarrhoea.Acta Paediatr 2005;94:44-47[PMID:15858959 DOI:10.1111/j.1651-2227.2005.tb01786.x]
17 Billoo AG,Memon MA,Khaskheli SA,Murtaza G,Iqbal K,Saeed Shekhani M,Siddiqi AQ.Role of a probiotic(Saccharomyces boulardii)in management and prevention of diarrhoea.World J Gastroenterol2006;12:4557-4560[PMID:16874872 DOI:10.3748/wjg.v12.i28.4557]
18 Htwe K,Yee KS,Tin M,Vandenplas Y.Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children:A randomized controlled study.Am J Trop Med Hyg 2008;78:214-216[PMID:18256417 DOI:10.4269/ajtmh.2008.78.214]
19 Kollaritsch H,Kremser P,Wiedermann G,Schneider O.Prevention of traveler's diarrhea:Comparison of different non antibiotic preparation.Travel Med Int 1989;9-17
20 Kollaritsch H,Holst H,Grobara P,Wiedermann G.[Prevention of traveler's diarrhea with Saccharomyces boulardii.Results of a placebo controlled double-blind study].Fortschr Med 1993;111:152-156[PMID:8486328]
21 Vidon N,Huchet B,Rambaud JC.[Influence of Saccharomyces boulardii on jejunal secretion in rats induced by cholera toxin].Gastroenterol Clin Biol 1986;10:13-16[PMID:3956910]
22 Czerucka D,Rampal P.Effect of Saccharomyces boulardii on cAMP-and Ca2+-dependent Cl-secretion in T84 cells.Dig Dis Sci 1999;44:2359-2368[PMID:10573387 DOI:10.1023/A:1026689628136]
23 Czerucka D,Roux I,Rampal P.Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells.Gastroenterology 1994;106:65-72[PMID:8276210DOI:10.1016/S0016-5085(94)94403-2]
24 Brand?o RL,Castro IM,Bambirra EA,Amaral SC,Fietto LG,Tropia MJ,Neves MJ,Dos Santos RG,Gomes NC,Nicoli JR.Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae.Appl Environ Microbiol 1998;64:564-568[PMID:9464394 DOI:10.1016/j.cattod.2009.07.111]
25 Toothaker RD,Elmer GW.Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.Antimicrob Agents Chemother 1984;26:552-556[PMID:6517545 DOI:10.1128/AAC.26.4.552]
26 Corthier G,Dubos F,Ducluzeau R.Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.Can J Microbiol 1986;32:894-896[PMID:3815159 DOI:10.1139/m86-164]
27 Corthier G,Lucas F,Jouvert S,Castex F.Effect of oral Saccharomyces boulardii treatment on the activity of Clostridium difficile toxins in mouse digestive tract.Toxicon 1992;30:1583-1589[PMID:1488767 DOI:10.1016/0041-0101(92)90030-9]
28 Koon HW,Su B,Xu C,Mussatto CC,Tran DH,Lee EC,Ortiz C,Wang J,Lee JE,Ho S,Chen X,Kelly CP,Pothoulakis C.Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.Am J Physiol Gastrointest Liver Physiol2016;311:G610-G623[PMID:27514478 DOI:10.1152/ajpgi.00150.2016]
29 Pothoulakis C,Kelly CP,Joshi MA,Gao N,O'Keane CJ,Castagliuolo I,Lamont JT.Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.Gastroenterology1993;104:1108-1115[PMID:8462799 DOI:10.1016/0016-5085(93)90280-P]
30 Castagliuolo I,LaMont JT,Nikulasson ST,Pothoulakis C.Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.Infect Immun 1996;64:5225-5232[PMID:8945570DOI:10.1016/S0928-8244(96)00073-9]
31 Chen X,Kokkotou EG,Mustafa N,Bhaskar KR,Sougioultzis S,O'Brien M,Pothoulakis C,Kelly CP.Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis.J Biol Chem 2006;281:24449-24454[PMID:16816386 DOI:10.1074/jbc.M605200200]
32 Qamar A,Aboudola S,Warny M,Michetti P,Pothoulakis C,LaMont JT,Kelly CP.Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.Infect Immun 2001;69:2762-2765[PMID:11254650 DOI:10.1128/IAI.69.4.2762-2765.2001]
33 Pontier-Bres R,Rampal P,Peyron JF,Munro P,Lemichez E,Czerucka D.The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B.anthracis LT toxin.Toxins(Basel)2015;7:4455-4467[PMID:26529015 DOI:10.3390/toxins7114455]
34 Czerucka D,Dahan S,Mograbi B,Rossi B,Rampal P.Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coliinfected T84 cells.Infect Immun 2000;68:5998-6004[PMID:10992512 DOI:10.1128/IAI.68.10.5998-6004.2000]
35 Dahan S,Dalmasso G,Imbert V,Peyron JF,Rampal P,Czerucka D.Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.Infect Immun 2003;71:766-773[PMID:12540556 DOI:10.1128/IAI.71.2.766-773.2003]
36 Wu X,Vallance BA,Boyer L,Bergstrom KS,Walker J,Madsen K,O'Kusky JR,Buchan AM,Jacobson K.Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.Am J Physiol Gastrointest Liver Physiol 2008;294:G295-G306[PMID:18032474 DOI:10.1152/ajpgi.00173.2007]
37 Buts JP,Dekeyser N,Stilmant C,Delem E,Smets F,Sokal E.Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation.Pediatr Res 2006;60:24-29[PMID:16690953 DOI:10.1203/01.pdr.0000220322.31940.29]
38 Rodrigues AC,Nardi RM,Bambirra EA,Vieira EC,Nicoli JR.Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.J Appl Bacteriol 1996;81:251-256[PMID:8810053 DOI:10.1111/j.1365-2672.1996.tb04325.x]
39 Martins FS,Dalmasso G,Arantes RM,Doye A,Lemichez E,Lagadec P,Imbert V,Peyron JF,Rampal P,Nicoli JR,Czerucka D.Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection.PLoS One 2010;5:e8925[PMID:20111723 DOI:10.1371/journal.pone.0008925]
40 Pontier-Bres R,Munro P,Boyer L,Anty R,Imbert V,Terciolo C,AndréF,Rampal P,Lemichez E,Peyron JF,Czerucka D.Saccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tract.PLoS One 2014;9:e103069[PMID:25118595 DOI:10.1371/journal.pone.0103069]
41 Pontier-Bres R,Prodon F,Munro P,Rampal P,Lemichez E,Peyron JF,Czerucka D.Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardii.PLoS One 2012;7:e33796[PMID:22442723 DOI:10.1371/journal.pone.0033796]
42 Mumy KL,Chen X,Kelly CP,McCormick BA.Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.Am J Physiol Gastrointest Liver Physiol 2008;294:G599-G609[PMID:18032477 DOI:10.1152/ajpgi.00391.2007]
43 Gedek BR.Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT104 to the surface of Saccharomyces boulardii.Mycoses 1999;42:261-264[PMID:10424093 DOI:10.1046/j.1439-0507.1999.00449.x]
44 Duman DG,Bor S,Ozütemiz O,Sahin T,O?uz D,I?tan F,Vural T,Sandkci M,I?ksal F,Sim?ek I,Soytürk M,Arslan S,Sivri B,Soykan I,Temizkan A,Be??k F,Kaymako?lu S,Kalayc C.Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication.Eur J Gastroenterol Hepatol 2005;17:1357-1361[PMID:16292090 DOI:10.1097/00042737-200512000-00015]
45 Cindoruk M,Erkan G,Karakan T,Dursun A,Unal S.Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy:A prospective randomized placebo-controlled doubleblind study.Helicobacter 2007;12:309-316[PMID:17669103 DOI:10.1111/j.1523-5378.2007.00516.x]
46 Sakarya S,Gunay N.Saccharomyces boulardii expresses neuraminidase activity selective forα2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells.APMIS 2014;122:941-950[PMID:24628732 DOI:10.1111/apm.12237]
47 Yang L,Tian ZB,Yu YN,Zhang CP,Li XY,Mao T,Jing X,Zhao WJ,Ding XL,Yang RM,Zhang SQ.Saccharomyces boulardii administration can inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection.Pathog Dis 2017;75[PMID:28115360 DOI:10.1093/femspd/ftx006]
48 Guilbaub JF.Traitement des candidoses digestives et cutanéo-muqueuses par l'Ultra-levureàhaute dose.Vie méd 1975;8:628-630
49 Ducluzeau R,Bensaada M.[Comparative effect of a single or continuous administration of"Saccharomyces boulardii"on the establishment of various strains of"candida"in the digestive tract of gnotobiotic mice].Ann Microbiol(Paris)1982;133:491-501[PMID:6762128 DOI:10.1016/0141-4607(82)90006-3]
50 Berg R,Bernasconi P,Fowler D,Gautreaux M.Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii.J Infect Dis 1993;168:1314-1318[PMID:8228371 DOI:10.1093/infdis/168.5.1314]
51 Algin C,Sahin A,Kiraz N,Sahintürk V,Ihtiyar E.Effectiveness of bombesin and Saccharomyces boulardii against the translocation of Candida albicans in the digestive tract in immunosuppressed rats.Surg Today 2005;35:869-873[PMID:16175469 DOI:10.1007/s00595-005-3049-9]
52 Jawhara S,Poulain D.Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis.Med Mycol 2007;45:691-700[PMID:17885943 DOI:10.1080/13693780701523013]
53 Krasowska A,Murzyn A,Dyjankiewicz A,?ukaszewicz M,Dziadkowiec D.The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation,adhesion and biofilm formation.FEMS Yeast Res 2009;9:1312-1321[PMID:19732158 DOI:10.1111/j.1567-1364.2009.00559.x]
54 Murzyn A,Krasowska A,Stefanowicz P,Dziadkowiec D,?ukaszewicz M.Capric acid secreted by S.boulardii inhibits C.albicans filamentous growth,adhesion and biofilm formation.PLoS One 2010;5:e12050[PMID:20706577 DOI:10.1371/journal.pone.0012050]
55 Murzyn A,Krasowska A,Augustyniak D,Majkowska-Skrobek G,?ukaszewicz M,Dziadkowiec D.The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407.FEMS Microbiol Lett 2010;310:17-23[PMID:20629753 DOI:10.1111/j.1574-6968.2010.02037.x]
56 Fidan I,Kalkanci A,Yesilyurt E,Yalcin B,Erdal B,Kustimur S,Imir T.Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans.Mycoses 2009;52:29-34[PMID:18627477 DOI:10.1111/j.1439-0507.2008.01545.x]
57 Buccigrossi V,Laudiero G,Russo C,Miele E,Sofia M,Monini M,Ruggeri FM,Guarino A.Chloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytes.PLoS One 2014;9:e99830[PMID:24918938 DOI:10.1371/journal.pone.0099830]
58 Rigothier MC,Maccario J,Vuong PN,Gayral P.[Effects of Saccharomyces boulardii yeast on trophozoites of Entamoeba histolytica in vitro and in cecal amebiasis in young rats].Ann Parasitol Hum Comp 1990;65:51-60[PMID:2221756 DOI:10.1051/parasite/1990652051]
59 Rigothier MC,Maccario J,Gayral P.Inhibitory activity of saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro.Parasitol Res 1994;80:10-15[PMID:8153119 DOI:10.1007/BF00932617]
60 Schroeder B,Winckler C,Failing K,Breves G.Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum.Dig Dis Sci 2004;49:1311-1317[PMID:15387362 DOI:10.1023/B:DDAS.0000037828.05100.52]
61 Krammer M,Karbach U.Antidiarrheal action of the yeast Saccharomyces boulardii in the rat small and large intestine by stimulating chloride secretion.Z Gastroenterol 1993;31:73-77
62 Girard P,Pansart Y,Lorette I,Gillardin JM.Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats.Dig Dis Sci 2003;48:770-774[PMID:12741470 DOI:10.1023/A:1022801228938]
63 Breves G,Faul K,Schr?der B,Holst H,Caspary WF,Stein J.Application of the colon-simulation technique for studying the effects of Saccharomyces boulardii on basic parameters of porcine cecal microbial metabolism disturbed by clindamycin.Digestion 2000;61:193-200[PMID:10773725 DOI:10.1159/000007757]
64 Schneider SM,Girard-Pipau F,Filippi J,Hebuterne X,Moyse D,Hinojosa GC,Pompei A,Rampal P.Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition.World J Gastroenterol 2005;11:6165-6169[PMID:16273644 DOI:10.3748/wjg.v11.i39.6165]
65 Buts JP,Bernasconi P,Vaerman JP,Dive C.Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii.Dig Dis Sci 1990;35:251-256[PMID:2302983 DOI:10.1007/bf01536771]
66 Jahn HU,Ullrich R,Schneider T,Liehr RM,Schieferdecker HL,Holst H,Zeitz M.Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers.Digestion1996;57:95-104[PMID:8786007 DOI:10.1159/000201320]
67 Collignon A,SandréC,Barc MC.[Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment].Gastroenterol Clin Biol 2010;34 Suppl 1:S71-S78[PMID:20889009 DOI:10.1016/S0399-8320(10)70024-5]
68 Thomas S,Przesdzing I,Metzke D,Schmitz J,Radbruch A,Baumgart DC.Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation.Clin Exp Immunol 2009;156:78-87[PMID:19161443 DOI:10.1111/j.1365-2249.2009.03878.x]
69 Thomas S,Metzke D,Schmitz J,D?rffel Y,Baumgart DC.Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis.Am J Physiol Gastrointest Liver Physiol 2011;301:G1083-G1092[PMID:21903765 DOI:10.1152/ajpgi.00217.2011]
70 Ibanez L,Pontier-Bres R,Larbret F,Rekima A,Verhasselt V,Blin-Wakkach C,Czerucka D.Saccharomyces boulardii strain CNCM I-745 modifies the mononuclear response in the small intetine of mice following Salmonella Typhimurium infection.Front Immunol 2019;10:643[DOI:10.3389/fimmu.2019.00643.eCollection2019]
71 Barc MC,Charrin-Sarnel C,Rochet V,Bourlioux F,SandréC,Boureau H,DoréJ,Collignon A.Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment:Influence of Saccharomyces boulardii.Anaerobe 2008;14:229-233[PMID:18511310 DOI:10.1016/j.anaerobe.2008.04.003]
72 Swidsinski A,Loening-Baucke V,Verstraelen H,Osowska S,Doerffel Y.Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea.Gastroenterology 2008;135:568-579[PMID:18570896 DOI:10.1053/j.gastro.2008.04.017]
73 Swidsinski A,Loening-Baucke V,Schulz S,Manowsky J,Verstraelen H,Swidsinski S.Functional anatomy of the colonic bioreactor:Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders.Syst Appl Microbiol 2016;39:67-75[PMID:26723852 DOI:10.1016/j.syapm.2015.11.002]
74 Kabbani TA,Pallav K,Dowd SE,Villafuerte-Galvez J,Vanga RR,Castillo NE,Hansen J,Dennis M,Leffler DA,Kelly CP.Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.Gut Microbes 2017;8:17-32[PMID:27973989 DOI:10.1080/19490976.2016.1267890]
75 MoréMI,Swidsinski A.Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis-a review.Clin Exp Gastroenterol 2015;8:237-255[PMID:26316791 DOI:10.2147/CEG.S85574]